NTproBNP is a useful early biomarker of bronchopulmonary dysplasia in very low birth weight infants

European Journal of Pediatrics
Paula Méndez-AbadIsabel Benavente-Fernández

Abstract

Bronchopulmonary dysplasia (BPD) is a severe complication of prematurity that impacts survival and neurodevelopment. Currently, no early marker exists which could help clinicians identify which preterm infants will develop BPD. Given the evidence that NTproBNP is elevated in children with BPD, we hypothesized that it could be used as an early marker of BPD development. We conducted a prospective cohort study including very low birth weight infants (VLBWI) admitted to our NICU between January 2015 and January 2017 in which we determined serial NTproBNP levels on days 1 and 3 and then weekly, until 49 days of life. A total of 101 patients were recruited (mean birth weight 1152 g (SD 247.5), mean gestational age 28.9 weeks (SD 1.9)). NTproBNP levels differed among infants who did and did not develop BPD from 14 to 35 days of life with the greatest difference on day 14 of life (non-BPD group (n = 86): 1155 (IQR 852-1908) pg/mL, BPD (n = 15): 9707 (IQR 3212-29,560) pg/mL; p = 0.0003). The presence of HsPDA did not account for higher levels of NTproBNP at day 14 (p = 0.165). We calculated an optimal cutoff point of 2264 pg/mL at 14 days of life (sensitivity 100%, specificity 86% and AUC 0.93).Conclusions: NTproBNP at 14 days of life ...Continue Reading

References

Jun 13, 2001·American Journal of Respiratory and Critical Care Medicine·A H Jobe, E Bancalari
Sep 19, 2003·Journal of Perinatology : Official Journal of the California Perinatal Association·Michele C WalshAvroy Fanaroff
Jun 3, 2006·Pediatrics·Ralph L da GracaPeter A M Auld
Mar 7, 2008·Journal of Perinatology : Official Journal of the California Perinatal Association·A El-KhuffashE J Molloy
Dec 17, 2009·American Journal of Perinatology·Leon JosephElie Picard
May 22, 2010·Early Human Development·Savina MannarinoMauro Stronati
May 24, 2011·Current Opinion in Pediatrics·Anne M Lenz
Oct 15, 2011·European Journal of Echocardiography : the Journal of the Working Group on Echocardiography of the European Society of Cardiology·Luc MertensUNKNOWN Association for European Pediatric Cardiologists (AEPC)
Feb 7, 2012·Statistics in Medicine·Xinhua Liu
Apr 16, 2013·Seminars in Perinatology·Sara K BerkelhamerRobin H Steinhorn
Nov 28, 2013·Pediatrics International : Official Journal of the Japan Pediatric Society·Gordana Markovic-SovticM Zorica Rakonjac
Feb 8, 2014·Journal of Perinatology : Official Journal of the California Perinatal Association·K KönigC P Barfield
Mar 19, 2014·Birth Defects Research. Part A, Clinical and Molecular Teratology·Erik A Jensen, Barbara Schmidt
Jan 19, 2016·Neonatology·Angela M MontgomeryConstance G Weismann
Mar 13, 2016·Pediatric Pulmonology·Kai KönigCharles P Barfield
Oct 21, 2016·American Journal of Physiology. Lung Cellular and Molecular Physiology·Kai KönigDan M Casalaz
Jul 7, 2018·Journal of Perinatology : Official Journal of the California Perinatal Association·Soham DasguptaSunil K Jain

❮ Previous
Next ❯

Citations

Jan 12, 2020·Journal of Perinatology : Official Journal of the California Perinatal Association·Tao XiongMohan Pammi
Jan 9, 2020·Journal of Perinatology : Official Journal of the California Perinatal Association·Buria NaeemSunil K Jain
Jun 20, 2019·Pediatric Pulmonology·Almudena Alonso-Ojembarrena, Simón Pedro Lubián-López
Feb 6, 2020·Frontiers in Pediatrics·Paula Méndez-AbadIsabel Benavente-Fernández
Nov 4, 2020·European Journal of Pediatrics·Agnes-Sophie FritzChristoph Hünseler

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.